Nuzenio

Pathos Ai

Pathos Ai news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 17 publisher sources 100/100 entity strength

Latest news

AstraZeneca (LSE:AZN) Signs Global Precision Oncology Diagnostics Alliance - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:51:01 GMT Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity NewsMedCity News · Tue, 04 Aug 2026 20:22:15 GMT Pathos AI Enters Two lIcensing Deals | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 19:07:22 GMT Pathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials - Tech TimesTech Times · Tue, 04 Aug 2026 19:03:51 GMT Pathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:01:14 GMT Eyes on Asia: Axiom, Pathos AI, Samsung Biologics - BioXconomyBioXconomy · Tue, 04 Aug 2026 15:19:19 GMT Pathos AI inks deals with AstraZeneca and Alphamab - thepharmaletter.comthepharmaletter.com · Tue, 04 Aug 2026 14:40:35 GMT M&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMT

Timeline

Fri, 07 Aug 2026 13:51:01 GMTAstraZeneca (LSE:AZN) Signs Global Precision Oncology Diagnostics Alliance - simplywall.st

Tue, 04 Aug 2026 20:22:15 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity News

Tue, 04 Aug 2026 19:07:22 GMTPathos AI Enters Two lIcensing Deals | PharmExec - Pharmaceutical Executive

Tue, 04 Aug 2026 19:03:51 GMTPathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials - Tech Times

Tue, 04 Aug 2026 17:01:14 GMTPathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm International

Tue, 04 Aug 2026 15:19:19 GMTEyes on Asia: Axiom, Pathos AI, Samsung Biologics - BioXconomy

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

AstraZeneca12 live mentions Alphamab10 live mentions Alphamab Oncology5 live mentions Proactive5 live mentions China4 live mentions PROTAC4 live mentions Pathos Communications4 live mentions Pathos AI Enters3 live mentions Bispecific ADC3 live mentions LSE2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pathos Ai.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.